Corporate Banner
Satellite Banner
Proteomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Lung Disease and Melanoma: a Common Molecular Mechanism?

Published: Monday, September 02, 2013
Last Updated: Monday, September 02, 2013
Bookmark and Share
Researchers have solved a biological mystery about the common genesis of many serious diseases such as asthma and metastatic melanoma.

Scientists have identified the first known pathway by which their cellular functions turn abnormal, and a healthy process goes haywire. The study is published in Cell Reports.

The team focused on an ancient gene family known as “18 glycosyl hydrolase (GH 18),” and in particular, one protein known as chitinase 3-like-1 (Chi3l1). This protein plays a critical role in the body’s response to foreign pathogens, augmenting the killing of bacteria while controlling inflammation and cell death to keep the immune response from harming normal tissue.

Although previous studies from this Yale team and colleagues have helped define the roles of Chi3l1 in biology, the mechanism by which it works — and triggers disease when overexpressed — was not known. The Yale team knew that Chi3l1 was not functioning as an enzyme would. They theorized that it acted, instead, by binding to a cellular receptor. Their studies led them to focus on a receptor known as IL-13Rα2, which was thought to be a so-called “decoy receptor” that binds molecules but does not induce cellular signaling or activate a biologic response.

Their experiments in mice proved that IL-13Rα2 was no decoy at all, but an active participant in the signaling pathway. The binding of overexpressed Chi3l1 and the receptor IL-13Rα2 began a cascade of subsequent reactions in the mice that resulted in lung disease, lung melanoma metastasis, and a host of other diseases.

“What we discovered was that when Chi3l1 is produced, IL-13Rα2 binds it and acts as a catalyst, triggering important biologic responses such as the control of cell death and production of inflammatory mediators,” said senior author Dr. Jack A. Elias, chair of internal medicine at Yale School of Medicine and a member of Yale Cancer Center.

Elias hopes that further research will identify more receptors in this family, and he sees a potential for developing therapies based on his team’s findings. “These molecules are expressed abnormally in a number of diseases, so the idea that you can control them is exciting. Perhaps we can develop an antibody or a small molecule that blocks their action and changes cellular function.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

New Type of Drug Can Target All Disease-causing Proteins
Current drugs block the actions of only about a quarter of known disease-causing proteins, but Yale University researchers have developed a technology capable of not just inhibiting, but destroying every protein it targets.
Monday, June 15, 2015
Single-Cell, 42-plexed Protein Analysis Achieved with a New Microchip Technology
A novel microdevice capable of detecting 42 unique immune effector proteins has been developed.
Tuesday, February 17, 2015
Tarantula Venom Holds Hope for New Painkillers
Screening more than 100 spider toxins, Yale researchers identified a protein from the venom of the Peruvian green velvet tarantula that blunts activity in pain-transmitting neurons.
Monday, February 17, 2014
Biomarkers Indicate Increased Risk of Death After Discharge from Cardiac Surgery
Following cardiac surgery, patients with elevated levels of kidney injury biomarkers are at a significantly higher risk of dying during the next three years, a Yale study has found.
Monday, December 23, 2013
Alzheimer’s Missing Link Found: Is a Promising Target for New Drugs
Researchers have discovered a protein that is the missing link in the complicated chain of events that lead to Alzheimer’s disease.
Monday, September 09, 2013
Yale Nobel Laureate Honored with Connecticut Medal of Science
Thomas Steitz will receive the 2013 Connecticut (CT) Medal of Science, the state’s top prize for technological achievement crucial to economic development.
Monday, April 22, 2013
Bacteria Yield Clues About Why Proteins go Bad in ALS and Alzheimer’s
Scientists are unsure why proteins form improperly and cluster together in bunches, a hallmark of neurodegenerative diseases.
Friday, November 02, 2012
Yale Scientists Find a Way to Make Disease-Causing Proteins Vulnerable to Drugs
Researchers have identified a novel way to design drugs for previously inaccessible proteins.
Friday, July 27, 2012
Yale Scientists Pinpoint Key Ingredient in Fighting Pneumonia
Study shows that a mysterious protein produced by a wide spectrum of living things is crucial in regulating the immune response to the most common form of pneumonia.
Friday, July 20, 2012
Yale Researchers Awarded Grant to Develop Treatment of Williams Syndrome
A $320,000 grant will be utilized to study the elastin gene in order to design new treatments for Williams Syndrome.
Wednesday, October 28, 2009
Researchers Announce that two Proteins have Unexpected Effects on Autoimmune Diseases Such as Lupus
Drugs that target these proteins could be important therapies for autoimmunity.
Wednesday, November 01, 2006
Scientific News
Lemon Juice and Human Norovirus
Citric acid may prevent the highly contagious norovirus from infecting humans, scientists discovered from the German Cancer Research Center.
Signature of Microbiomes Linked to Schizophrenia
Studying microbiomes in throat may help identify causes and treatments of brain disorder.
Structural Discoveries Could Aid in Better Drug Design
Scientists have uncovered the structural details of how some proteins interact to turn two different signals into a single integrated output.
Protein Found to Play a Key Role in Blocking Pathogen Survival
Calprotectin fends off microbial invaders by limiting access to iron, an important nutrient.
Study Identifies the Off Switch for Biofilm Formation
New discovery could help prevent the formation of infectious bacterial films on hospital equipment.
How DNA ‘Proofreader’ Proteins Pick and Edit Their Reading Material
Researchers from North Carolina State University and the University of North Carolina at Chapel Hill have discovered how two important proofreader proteins know where to look for errors during DNA replication and how they work together to signal the body’s repair mechanism.
Protein Found to Control Inflammatory Response
A new Northwestern Medicine study shows that a protein called POP1 prevents severe inflammation and, potentially, diseases caused by excessive inflammatory responses.
X-ray Laser Experiment Could Help in Designing Drugs for Brain Disorders
Scientists found that when two protein structures in the brain join up, they act as an amplifier for a slight increase in calcium concentration, triggering a gunshot-like release of neurotransmitters from one neuron to another.
Team Identifies Structure of Tumor-Suppressing Protein
An international group of researchers led by Carnegie Mellon University physicists Mathias Lösche and Frank Heinrich have established the structure of an important tumor suppressing protein, PTEN.
Why We’re Smarter Than Chickens
Toronto researchers have discovered that a single molecular event in our cells could hold the key to how we evolved to become the smartest animal on the planet.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!